A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors

Status:
Completed

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

Phase 1, open-labeled, safety and tolerability study for the treatment of subjects with relapsed or refractory solid tumors.

Phase 1

Biogen